Skip to content

Study on the cerebral vision mechanism of electroacupuncture on the regulation function of myopia

Study on the therapeutic mechanism of key technologies in TCM prevention and control

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004899
Enrollment
Unknown
Registered
2021-05-28
Start date
2021-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

Sponsors

Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1.Pseudomyopia group: (1) Aged from 6 to 16 years; (2) Eyes meet the classification criteria of true and false myopia formulated by the Eye Branch of the Chinese Medical Association in 1985, that is, the patient's far vision is lower than normal, near vision is normal, and after the use of atropine paralysis of the ciliary muscle, myopia disappears, showing emmetropia or mild hyperopia is regarded as false myopia; (3) Right hand; (4) Informed consent, and voluntarily signed informed consent. 2.True myopia group: (1) Ball mirror = 1.0; (5) Informed consent, and voluntarily signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Pseudomyopia group: (1) Single or double-eye lens > 3.00D or cylindrical lens > 1.00D; (2) Refractive aberration > 2.00D; (3) Patients with binocular or monocular organic lesions that affect vision, such as corneal, iris, and fundus lesions; (4) Long-term use of relevant treatment without termination; (5) Patients with other serious systemic diseases, such as cardiovascular, cerebrovascular, liver, kidney, hematopoietic system and mental diseases; (6) Participants in other clinical trials; (7) According to the judgment of the researchers, other lesions that reduce the possibility of joining the group or complicate the joining the group are prone to loss of follow-up. 2.True myopia group: (1) Patients with binocular or monocular organic lesions that affect vision, such as corneal, iris, lens and fundus lesions; (2) Patients with severe systemic diseases, such as cardiovascular, cerebrovascular, liver, kidney, hematopoietic system and mental diseases; patients with allergic constitution or allergic to medical silicone; psychiatric patients; (3) Participants in other clinical trials; (4) Compliance with diagnosis, but objective conditions can not adhere to treatment, easy to lose follow-up.

Design outcomes

Primary

MeasureTime frame
intraocular pressure;deoxyhemoglobin;ocular accommodation;diopter;oxyhemoglobin;total hemoglobin;vision;

Countries

China

Contacts

Public ContactBi Hongsheng

Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine

hongshengbi1@163.com+86 13953113696

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026